To view this email as a web page, click here.

 
EULAR 2019 Reports
 
Highlights from EULAR 2019: Treatments for Gout, PsA, Rheumatoid Arthritis, More
EULAR 2019 wraps this weekend in Madrid. In this slideshow, we highlight some of the most noteworthy findings, beginning with a possible new treatment combination for patients who have both gout and kidney disease.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.